PubMed: Cannabidiol for the Treatment of Pediatric Epilepsy

PubMed: Cannabidiol for the Treatment of Pediatric Epilepsy

Pediatr Ann. 2023 Oct;52(10):e369-e372. doi: 10.3928/19382359-20230829-04. Epub 2023 Oct 1.

ABSTRACT

Pediatric epilepsy is a debilitating disease cluster that is much less researched than adult epilepsy. With approximately 30% of patients with pediatric epilepsy experiencing refractory seizures, novel treatment modalities are sometimes necessary to provide benefit. The use of marijuana, and more specifically cannabidiol, in people with seizures is much more broadly researched in adults compared with pediatric patients, although several recent review articles have been published. This article seeks to provide a pathophysiological basis for cannabidiol in epilepsy, discuss commercially available products and nonpharmaceutical marijuana, and review recent evidence in pediatric epilepsy. [Pediatr Ann. 2023;52(10):e369-e372.].

PMID:37820705 | DOI:10.3928/19382359-20230829-04

https://pubmed.ncbi.nlm.nih.gov/37820705/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1NqsX9BbHlDygQ8TcgAlJilHgPpiuKQtyIr–a3-xbLzPoB9xM&fc=20220928170152&ff=20231012190617&v=2.17.9.post6+86293ac October 11, 2023 10:00 am